Japan Single-Use Bioprocessing Products Market Size, Share, Industry, Forecast and outlook (2024-2031)

Japan Single-Use Bioprocessing Products Market is segmented By Product (Single-use Bioreactors (SUBs), Tubing, Connectors, Disposable Mixers Bags, Containers, Disposable Filter Cartridges, Sampling system, Tangential Flow Filtration, Membrane Adsorbers, Purification Devices, Preassembled, Others), By Application (Filtration, Storage, Cell Culture, Mixing, Purification), By End-User (Biopharmaceutical Manufacturers, Life Science R&D Companies & Academic Research Institutes, CROs, CMOs, Others) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Report Overview

Japan Single-Use Bioprocessing Products Market reached US$ XX million in 2023 and is expected to reach US$ XX million by 2031, growing at a CAGR of XX% during the forecast period 2024-2031

Single-use bioprocessing is a relatively new concept in the production of biopharmaceuticals. All of the active pharmaceutical ingredients must be sterile for their administration. Therefore, they must be produced under aseptic conditions. Single-use systems are a promising future in biopharmaceutical processing, offering significant advantages over traditional reusable and disposable systems. They promote sustainability by eliminating chemicals and resources needed for sterilisation and with minimal cost and time. They also eliminate cross-contamination risk as the product flow path is discarded and replaced after each batch, reducing the risk of cross-contamination.

Market Scope

For more details on this report Request for Sample

Market Dynamics: Drivers & Restraints

The rising biopharmaceutical production in Japan

The rising biopharmaceutical production in Japan is expected to drive the market for single-use bioprocessing products in Japan. Japan’s, biopharmaceutical sector has been experiencing robust growth, driven by increasing demand for biologics, including monoclonal antibodies, vaccines, and cell and gene therapies. Many established manufacturers have been expanding their production facilities in Japan, to increase their production volume.

For instance, AGC Inc. plans to build a new manufacturing facility at Yokohama Technical Center in Japan, aiming to meet global demand for biologics and advanced therapy medicinal products. The facility, expected to be operational in 2026, will offer pre-clinical through commercial services for mammalian-based protein biologics, cell therapies, and mRNA.

Likewise, many biopharmaceutical manufacturers are expanding their production sites in Japan, which is expected to create a huge demand for single-use bioprocessing equipment in the forecast period.

Environmental concerns

The use of single-use bioprocessing products in Japan faces significant environmental challenges due to their reliance on plastics. These systems generate significant amounts of waste, contributing to environmental pollution and increasing the burden on waste disposal systems. Japan's strict environmental regulations and societal emphasis on reducing plastic pose challenges for the widespread adoption of these products. 

For more details on this report – Request for Sample

Market Segment Analysis

The Japan single-use bioprocessing products market is segmented based on product type, application, end-user, and region.

The single-use bioreactors (subs) from the product type segment accounted for approximately 31.3% of the Japan single-bioprocessing products  market share

The single-use bioreactors (subs) from the product type segment accounted for approximately 31.3%. The bioreactors are essential components of the biopharmaceuticals manufacturing process, which uses the culture and growth of cells to produce biological drugs. Single-use bioreactors are one of the widely used single-use bioprocessing products due to the several advantages it offers, such as flexibility, cost efficiency, and rapid deployment.

Moreover, the single-use bioreactors require low capital Investment, as they eliminate the need for infrastructure and equipment for cleaning and sterilization. This is mainly important parameter for the research and academic institutes which are higly focused on the biopharmaceutical drug discovery and development.

Several companies that are indigenous to Japan such as SATAKE MultiMix Corporation and foreign companies such as Thermofischer Scientific Inc provide single-use bioreactors in the country, creating no disturbance in the access of this instrument.

Market Major Players

The major global players in the market include Thermo Fisher Scientific Inc, SATAKE MultiMix Corporation, Sartorius AG, C tiva, Asahi Kasei, Merck KGaA, Eppendorf AG, Boehringer Ingelheim International GmbH, ZACROS, REPROCELL Inc among others.

Key Developments

• In April 2024, GVS Japan K.K. announced the official launch of single-use related products optimized for biopharmaceutical manufacturing.

Why Purchase the Report?

• To visualize the Japan single-use bioprocessing products market segmentation based on product type, application, end-user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of the Japan single-use bioprocessing products market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The Japan single-use bioprocessing products market report would provide approximately 64 tables, 61 figures, and 186 pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies